Phase I multicenter trial of BMS-690514: Safety, pharmacokinetic profile, biological effects, and early clinical evaluation in patients with advanced solid tumors and non-small cell lung cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 2564-2564 ◽  
Author(s):  
R. Bahleda ◽  
E. Felip ◽  
R. S. Herbst ◽  
N. H. Hanna ◽  
S. A. Laurie ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Biological Effects ◽  
Pharmacokinetic Profile ◽  
Multicenter Trial ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung

A phase I study of R-(-)-gossypol (AT-101) in combination with cisplatin (P) and etoposide (E) in patients (pts) with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3040-3040
Author(s):  
A. M. Traynor ◽  
J. Kolesar ◽  
R. M. Marnocha ◽  
J. C. Eikhoff ◽  
D. B. Alberti ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung ◽  
Extensive Stage

A phase I study of r-(-)-gossypol (AT-101, NSC 726190) in combination with cisplatin (P) and etoposide (E) in patients with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e13030-e13030 ◽  
Author(s):  
T. A. Leal ◽  
W. R. Schelman ◽  
A. M. Traynor ◽  
J. Kolesar ◽  
R. M. Marnocha ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung ◽  
Extensive Stage

scholarly journals A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

2013 ◽  
Vol 32 (2) ◽  
pp. 295-302 ◽  
Author(s):  
William R. Schelman ◽  
Tabraiz A. Mohammed ◽  
Anne M. Traynor ◽  
Jill M. Kolesar ◽  
Rebecca M. Marnocha ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung ◽  
Extensive Stage

scholarly journals Phase I Study of Two Different Schedules of Bortezomib and Pemetrexed in Advanced Solid Tumors with Emphasis on Non-small Cell Lung Cancer

2007 ◽  
Vol 2 (12) ◽  
pp. 1112-1116 ◽  
Author(s):  
Angela M. Davies ◽  
Cheryl Ho ◽  
Alex S. Metzger ◽  
Laurel A. Beckett ◽  
Scott Christensen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung

scholarly journals A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

2018 ◽  
Vol 25 (2) ◽  
pp. 496-505 ◽  
Author(s):  
Florence Atrafi ◽  
Harry J.M. Groen ◽  
Lauren A. Byers ◽  
Elena Garralda ◽  
Martijn P. Lolkema ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Dose Escalation Study ◽  
Extensive Stage

A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer

2012 ◽  
Vol 31 (1) ◽  
pp. 115-125 ◽  
Author(s):  
A. Dasari ◽  
L. Gore ◽  
W. A. Messersmith ◽  
S. Diab ◽  
A. Jimeno ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Renal Cell Carcinoma ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung

Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 8063-8063 ◽  
Author(s):  
Hendrik-Tobias Arkenau ◽  
Jasgit C. Sachdev ◽  
Monica M. Mita ◽  
Rafal Dziadziuszko ◽  
Chia-Chi Lin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Potent Inhibitor ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Small Cell Lung ◽  
Alk Positive

P47.02 EV-202: Phase 2 Study of Enfortumab Vedotin for Previously Treated Advanced Solid Tumors Including Non-Small Cell Lung Cancer

2021 ◽  
Vol 16 (10) ◽  
pp. S1096-S1097
Author(s):  
K. Muro ◽  
J. Yang Bruce ◽  
J. Baranda ◽  
T. Feinstein ◽  
X. Li ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Solid Tumors ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Solid Tumors ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document